Sign In
test

Stephen Scipione

Adar1 Capital Management, Llc

Assets Managed
$1.699B
Holdings
300
Last Quarter
2026 - Q1
Filed Date
8d ago
Growth Rate
24.76%(2Q avg: 26.33%)
Sustained Growth
5 quarters

Portfolio positions

This chart displays the top 10 holdings in Adar1 Capital Management, Llc's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 300 positions.

Assets under management

The assets under management (AUM) of Adar1 Capital Management, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 5 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 1.699B in assets, with a quarterly growth rate of 24.76% and a 2-quarter average growth rate of 26.33%. The portfolio is managed by Stephen Scipione, and others.

Portfolio holdings

InvestmentPortfolio %Reported Value
ABVX
Abivax Sa-adr
Recent Activity
Increased 9.17%
9.43%
$160.123M
1.438M shares@ $111.36 avg price
PTGX
Protagonist Therapeutics Inc
Recent Activity
Decreased -5.24%
6.17%
$104.78M
994,119 shares@ $105.41 avg price
ROIV
Roivant Sciences Ltd
Recent Activity
Decreased -4.17%
5.36%
$91.02M
3.286M shares@ $27.7 avg price
IMVT
Immunovant Inc
Recent Activity
Increased 7.99%
3.92%
$66.547M
2.679M shares@ $24.84 avg price
TERN
Terns Pharmaceuticals Inc
Recent Activity
Increased 105.82%
3.46%
$58.767M↑ Call
1.115M shares@ $52.72 avg price
SPY
Spdr S&p 500 Etf Trust
Recent Activity
Increased 38.88%
2.91%
$49.387M
75,940 shares@ $650.35 avg price
CYTK
Cytokinetics Inc
Recent Activity
Increased 17.11%
2.46%
$41.692M
632,556 shares@ $65.92 avg price
CRNX
Crinetics Pharmaceuticals In
Recent Activity
Increased 268.28%
2.44%
$41.381M
1.139M shares@ $36.33 avg price
BOXX
Alpha Architect 1-3 Mnth Box
Recent Activity
2.31%
$39.204M
337,125 shares@ $116.29 avg price
DNLI
Denali Therapeutics Inc
Recent Activity
Increased 3490.95%
2.12%
$35.932M
1.871M shares@ $19.2 avg price

1-10 of 300